Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Abstract B012: Genomic and epigenomic drivers of double-negative metastatic prostate cancer

Cancer Res (2023) 83 (11_Supplement): B012.

https://doi.org/10.1158/1538-7445.PRCA2023-B012

Published: 02 June 2023

View articletitled, Abstract B012: Genomic and epigenomic drivers of double-negative metastatic prostate cancer

Journal Articles

Abstract 3315: Evaluating biomarker potential of germline genomic factors for predicting clinical outcomes in prostate cancer

Nicole Zeltser, Kathleen E. Houlahan, Sarah M. Al-Hiyari, Stefan E. Eng, Yash Patel, Takafumi N. Yamaguchi, Shu Tao, Rong Rong Huang, Robert E. Reiter, Huihui Ye, Adam S. Kinnaird, Paul C. Boutros

Cancer Res (2023) 83 (7_Supplement): 3315.

https://doi.org/10.1158/1538-7445.AM2023-3315

Published: 04 April 2023

View articletitled, Abstract 3315: Evaluating biomarker potential of germline genomic factors for predicting clinical outcomes in prostate cancer

Journal Articles

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Martin Sjöström, Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha, Arian Lundberg, Cameron Herberts, Adam Foye, Rahul Aggarwal, Junjie T. Hua, Haolong Li, Anna Bergamaschi, Corinne Maurice-Dror, Ashutosh Maheshwari, Sujun Chen, Sarah W.S. Ng, Wenbin Ye, Jessica Petricca, Michael Fraser, Lisa Chesner, Marc D. Perry, Thaidy Moreno-Rodriguez, William S. Chen, Joshi J. Alumkal, Jonathan Chou, Alicia K. Morgans, Tomasz M. Beer, George V. Thomas, Martin Gleave, Paul Lloyd, Tierney Phillips, Erin McCarthy, Michael C. Haffner, Amina Zoubeidi, Matti Annala, Robert E. Reiter, Matthew B. Rettig, Owen N. Witte, Lawrence Fong, Rohit Bose, Franklin W. Huang, Jianhua Luo, Anders Bjartell, Joshua M. Lang, Nupam P. Mahajan, Primo N. Lara, Christopher P. Evans, Phuoc T. Tran, Edwin M. Posadas, Chuan He, Xiao-Long Cui, Jiaoti Huang, Wilbert Zwart, Luke A. Gilbert, Christopher A. Maher, Paul C. Boutros, Kim N. Chi, Alan Ashworth, Eric J. Small, Housheng H. He, Alexander W. Wyatt, David A. Quigley, Felix Y. Feng

Cancer Res (2022) 82 (21): 3888–3902.

https://doi.org/10.1158/0008-5472.CAN-22-1123

Published: 02 November 2022

View articletitled, The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Includes: Supplementary data

Journal Articles

Abstract 1502: Pre-conditioning modifies the tumor microenvironment to enhance solid tumor CAR T cell efficacy and endogenous immunity

John P. Murad, Dileshni Tilakawardane, Anthony K. Park, Kelly T. Kennewick, Lupita S. Lopez, Hee J. Lee, Brenna J. Gittins, Wen-Chung Chang, Chau P. Tran, Catalina Martinez, Anna M. Wu, Robert E. Reiter, Tanya B. Dorff, Stephen J. Forman, Saul J. Priceman

Cancer Res (2021) 81 (13_Supplement): 1502.

https://doi.org/10.1158/1538-7445.AM2021-1502

Published: 01 July 2021

View articletitled, Abstract 1502: Pre-conditioning modifies the tumor microenvironment to enhance solid tumor CAR T cell efficacy and endogenous immunity

Journal Articles

Abstract 1775: Development of fully humanized N-cadherin monoclonal antibodies for treatment of castration resistant prostate cancer

Evelyn A. Kono, Naoko Kobayashi, Kirstin Zettlitz, Keyu Li, Joyce Yamashiro, Chun Wang, Anna Wu, Robert E. Reiter

Cancer Res (2018) 78 (13_Supplement): 1775.

https://doi.org/10.1158/1538-7445.AM2018-1775

Published: 01 July 2018

View articletitled, Abstract 1775: Development of fully humanized N-cadherin monoclonal antibodies for treatment of castration resistant prostate cancer

Journal Articles

Abstract 5901: The role of POU3F2 in the aggressive behavior of neuroendocrine prostate cancer

Naoko Kobayashi, Dai Hong, Chun Wang, Joyce Yamashiro, Johnny Guan, Robert E. Reiter

Cancer Res (2018) 78 (13_Supplement): 5901.

https://doi.org/10.1158/1538-7445.AM2018-5901

Published: 01 July 2018

View articletitled, Abstract 5901: The role of POU3F2 in the aggressive behavior of neuroendocrine prostate cancer

Journal Articles

Abstract 1856: Dual-modality immunoPET/fluorescence imaging of prostate cancer utilizing ⁸⁹Zr- or ¹²⁴I-Cy5.5-anti-PSCA cys-minibody

Wen-Ting K. Tsai, Kirstin A. Zettlitz, Richard Tavaré, Felix B. Salazar, Robert E. Reiter, Anna M. Wu

Cancer Res (2017) 77 (13_Supplement): 1856.

https://doi.org/10.1158/1538-7445.AM2017-1856

Published: 01 July 2017

View articletitled, Abstract 1856: Dual-modality immunoPET/fluorescence imaging of prostate cancer utilizing 89Zr- or 124I-Cy5.5-anti-PSCA cys-minibody

Journal Articles

Abstract LB-279: N-cadherin promotes castration-resistant prostate cancer progression by enhancing stem cell properties of prostate cancer cells

Shu Lin, Tanya Stonyanova, Evelyn Kono, Jaclyn Matsuura, Naoko Kobayashi, Joyce Yamashiro, Dai Hong, Owen N. Witte, Andrew S. Goldstein, Robert E. Reiter

Cancer Res (2016) 76 (14_Supplement): LB-279.

https://doi.org/10.1158/1538-7445.AM2016-LB-279

Published: 15 July 2016

View articletitled, Abstract LB-279: N-cadherin promotes castration-resistant prostate cancer progression by enhancing stem cell properties of prostate cancer cells

Journal Articles

Abstract 3021: Roles of EMT on stem cell properties of prostate stem and cancer cells during castration-resistant prostate cancer progression

Shu Lin, Evelyn Kono, Joyce Yamashiro, Sean Lee, Owen Witte, Andrew Goldstein, Robert E. Reiter

Cancer Res (2014) 74 (19_Supplement): 3021.

https://doi.org/10.1158/1538-7445.AM2014-3021

Published: 01 October 2014

View articletitled, Abstract 3021: Roles of EMT on stem cell properties of prostate stem and cancer cells during castration-resistant prostate cancer progression

Journal Articles

Abstract 3310: N-cadherin promotes docetaxel resistance through upregulated TLR4 signaling in castration resistant prostate cancers

Tatsuya Shimomura, Evelyn Kono, Chau P. Tran, Joyce Yamashiro, Shu Lin, Sean Hyung-Kwon Lee, Zev A. Wainberg, Robert E. Reiter

Cancer Res (2014) 74 (19_Supplement): 3310.

https://doi.org/10.1158/1538-7445.AM2014-3310

Published: 01 October 2014

View articletitled, Abstract 3310: N-cadherin promotes docetaxel resistance through upregulated TLR4 signaling in castration resistant prostate cancers

Journal Articles

Abstract 677: Co-targeting of AR and N-cadherin with Enzalutamide and 2A9 monoclonal antibody to treat castration resistant prostate cancer

Evelyn A. Kono, Sean Hyung-Kwon Lee, Tatsuya Shimomura, Shu Lin, Joyce Yamashiro, Robert E. Reiter

Cancer Res (2014) 74 (19_Supplement): 677.

https://doi.org/10.1158/1538-7445.AM2014-677

Published: 01 October 2014

View articletitled, Abstract 677: Co-targeting of AR and N-cadherin with Enzalutamide and 2A9 monoclonal antibody to treat castration resistant prostate cancer

Journal Articles

Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging

Cancer Res (2014) 74 (17): 4638–4652.

https://doi.org/10.1158/0008-5472.CAN-13-3534

Published: 01 September 2014

View articletitled, Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging

Journal Articles

Abstract 4283: Evaluation of PSCA-specific minibody for in vivo imaging

Chau P. Tran, Scott Knowles, Tove Olafsen, Eric J. Lepin, Anna M. Wu, Robert E. Reiter

Cancer Res (2011) 71 (8_Supplement): 4283.

https://doi.org/10.1158/1538-7445.AM2011-4283

Published: 15 April 2011

View articletitled, Abstract 4283: Evaluation of PSCA-specific minibody for in vivo imaging

Journal Articles

Abstract 5052: N-cadherin monoclonal antibody as a therapeutic agent against chemoresistance in prostate cancer

Tatsuya Shimomura, Evelyn Kono, Chao P. Tran, Joyce Yamashiro, Zev A. Wainberg, Robert E. Reiter

Cancer Res (2011) 71 (8_Supplement): 5052.

https://doi.org/10.1158/1538-7445.AM2011-5052

Published: 15 April 2011

View articletitled, Abstract 5052: N-cadherin monoclonal antibody as a therapeutic agent against chemoresistance in prostate cancer

Journal Articles

Abstract 3623: Monoclonal antibody against the 4th extracellular domain of N-cadherin affects FGF2 mediated pathways in prostate cancer

Evelyn A. Kono, Chau P. Tran, Joyce Yamashiro, Tatsuya Shimomura, Robert E. Reiter

Cancer Res (2011) 71 (8_Supplement): 3623.

https://doi.org/10.1158/1538-7445.AM2011-3623

Published: 15 April 2011

View articletitled, Abstract 3623: Monoclonal antibody against the 4th extracellular domain of N-cadherin affects FGF2 mediated pathways in prostate cancer

Journal Articles

Androgen Receptor and Invasion in Prostate Cancer

Takahito Hara, Hideyo Miyazaki, Aram Lee, Chau P. Tran, Robert E. Reiter

Cancer Res (2008) 68 (4): 1128–1135.

https://doi.org/10.1158/0008-5472.CAN-07-1929

Published: 15 February 2008

View articletitled, Androgen Receptor and Invasion in Prostate Cancer

Includes: Supplementary data

Journal Articles

Anti–Prostate Stem Cell Antigen Monoclonal Antibody 1G8 Induces Cell Death In vitro and Inhibits Tumor Growth In vivo via a Fc-Independent Mechanism

Zhennan Gu, Joyce Yamashiro, Evelyn Kono, Robert E. Reiter

Cancer Res (2005) 65 (20): 9495–9500.

https://doi.org/10.1158/0008-5472.CAN-05-2086

Published: 17 October 2005

View articletitled, Anti–Prostate Stem Cell Antigen Monoclonal Antibody 1G8 Induces Cell Death In vitro and Inhibits Tumor Growth In vivo via a Fc-Independent Mechanism

Journal Articles

Reg IV gene exprssion increases as prostate cancer progresses

Zhennan Gu, Mark A. Rubin, Yu Yang, Samuel E. Deprimo, Hongjuan Zhou, Steve Horvath, James D. Brooks, Loda Massimo, Robert E. Reiter

Cancer Res (2005) 65 (9_Supplement): 746.

Published: 01 May 2005

View articletitled, Reg IV gene exprssion increases as prostate cancer progresses

Journal Articles

Biological activity and microPET imaging properties of chimeric and humanized anti-prostate stem cell antigen (PSCA) antibodies

Zhennan Gu, Tove Olafsen, Mark Sherman, Sherie L. Morrison, Anna M. Wu, Robert E. Reiter

Cancer Res (2005) 65 (9_Supplement): 164.

Published: 01 May 2005

View articletitled, Biological activity and microPET imaging properties of chimeric and humanized anti-prostate stem cell antigen (PSCA) antibodies

Journal Articles

Prostate Stem Cell Antigen Is Overexpressed in Human Transitional Cell Carcinoma

Nordine Amara, Ganesh S. Palapattu, Matthew Schrage, Zhennan Gu, George V. Thomas, Fred Dorey, Jonathan Said, Robert E. Reiter

Cancer Res (2001) 61 (12): 4660–4665.

Published: 01 June 2001

View articletitled, Prostate Stem Cell Antigen Is Overexpressed in Human Transitional Cell Carcinoma

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract B012: Genomic and epigenomic drivers of double-negative metastatic prostate cancer

Abstract 3315: Evaluating biomarker potential of germline genomic factors for predicting clinical outcomes in prostate cancer

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Abstract 1502: Pre-conditioning modifies the tumor microenvironment to enhance solid tumor CAR T cell efficacy and endogenous immunity

Abstract 1775: Development of fully humanized N-cadherin monoclonal antibodies for treatment of castration resistant prostate cancer

Abstract 5901: The role of POU3F2 in the aggressive behavior of neuroendocrine prostate cancer

Abstract 1856: Dual-modality immunoPET/fluorescence imaging of prostate cancer utilizing ⁸⁹Zr- or ¹²⁴I-Cy5.5-anti-PSCA cys-minibody

Abstract LB-279: N-cadherin promotes castration-resistant prostate cancer progression by enhancing stem cell properties of prostate cancer cells

Abstract 3021: Roles of EMT on stem cell properties of prostate stem and cancer cells during castration-resistant prostate cancer progression

Abstract 3310: N-cadherin promotes docetaxel resistance through upregulated TLR4 signaling in castration resistant prostate cancers

Abstract 677: Co-targeting of AR and N-cadherin with Enzalutamide and 2A9 monoclonal antibody to treat castration resistant prostate cancer

Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging

Abstract 4283: Evaluation of PSCA-specific minibody for in vivo imaging

Abstract 5052: N-cadherin monoclonal antibody as a therapeutic agent against chemoresistance in prostate cancer

Abstract 3623: Monoclonal antibody against the 4th extracellular domain of N-cadherin affects FGF2 mediated pathways in prostate cancer

Androgen Receptor and Invasion in Prostate Cancer

Anti–Prostate Stem Cell Antigen Monoclonal Antibody 1G8 Induces Cell Death In vitro and Inhibits Tumor Growth In vivo via a Fc-Independent Mechanism

Reg IV gene exprssion increases as prostate cancer progresses

Biological activity and microPET imaging properties of chimeric and humanized anti-prostate stem cell antigen (PSCA) antibodies

Prostate Stem Cell Antigen Is Overexpressed in Human Transitional Cell Carcinoma

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only